Candriam S.C.A. Boston Scientific Corp Transaction History
Candriam S.C.A.
- $17.1 Billion
- Q3 2024
A detailed history of Candriam S.C.A. transactions in Boston Scientific Corp stock. As of the latest transaction made, Candriam S.C.A. holds 474,915 shares of BSX stock, worth $41.6 Million. This represents 0.23% of its overall portfolio holdings.
Number of Shares
474,915
Previous 436,741
8.74%
Holding current value
$41.6 Million
Previous $33.6 Million
18.33%
% of portfolio
0.23%
Previous 0.21%
Shares
25 transactions
Others Institutions Holding BSX
# of Institutions
1,533Shares Held
1.19BCall Options Held
7.11MPut Options Held
9.51M-
Vanguard Group Inc Valley Forge, PA131MShares$11.5 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY126MShares$11.1 Billion0.22% of portfolio
-
State Street Corp Boston, MA62.8MShares$5.5 Billion0.22% of portfolio
-
Primecap Management CO Pasadena, CA37.8MShares$3.31 Billion2.37% of portfolio
-
Wellington Management Group LLP Boston, MA32.8MShares$2.87 Billion0.49% of portfolio
About BOSTON SCIENTIFIC CORP
- Ticker BSX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,431,609,984
- Market Cap $125B
- Description
- Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...